EGFR and glioblastoma: Upon capture, CTCs were stained with a dedicated GBM CTC antibody cocktail containing antibodies against EGFR, Ki67 and the microtubule-associated protein EB1, as well as against the WBC marker CD45 to exclude leukocyte contamination (Supplementary Fig. 2).